GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma.
ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid ...
Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...
The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...
New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...
As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer (NSCLC), the British pharma has rolled out early data from a trial ...
The Mazda CX-90 is a three-row midsize family SUV that debuted in 2024. I was impressed by the CX-90's spirited driving dynamics, luxurious cabin, and bold styling. I was less impressed by its ...
eGFR is calculated using a simple blood test to ... Many individuals experience no symptoms until significant kidney damage (85-90%) has occurred. Even in advanced stages, symptoms can be subtle ...
The normal eGFR value is 90 or above. However, a value as low as 60 may also indicate normal kidney function if there are no other kidney-related symptoms. 3 Physicians recommend an eGFR blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback